Blood Thinner Side Effects in the Emergency Room
Part of Heart & circulation clinical trials.
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You went to the emergency department at Besançon University Hospital between January 2018 and December 2019.
- You were taking one of these blood thinners: acenocoumarol, apixaban, dabigatran, fluindione, rivaroxaban, or warfarin.
- You did not stop taking your blood thinner for more than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
This trial compares two blood thinners (bivalirudin and heparin) during a procedure to open blocked heart arteries (PCI) in patients with a recent heart attack or unstable angina who also have a high risk of bleeding. The goal is to see which drug works better and is safer for patients like you.
This study collects information from patients who come to the emergency room with gastrointestinal bleeding while taking certain newer blood thinners. It aims to better understand and manage this type of bleeding.
This trial checks if patients leaving the emergency room or short-stay units while on a blood thinner (anticoagulant) have a higher chance of bleeding or clotting problems. It aims to help doctors give better advice to prevent these issues.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.